Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products>Product Directory
  Product Directory
Scale-up

AAIPharma Services
AAIPharma Services
Request a quote
More information
Alkermes Contract Pharma Services
Alkermes
Request a quote
More information
Almac Group
Almac Group
Request a quote
More information
Boehringer Ingelheim RCV GmbH & Co KG
Boehringer Ingelheim
Request a quote
More information
Catalent Pharma Solutions
Catalent Pharma Solutions
Request a quote
More information
Corden Pharma
Corden Pharma
Request a quote
More information
Enzon Pharmaceuticals, Inc.
Enzon Pharmaceuticals, Inc.
Request a quote
More information
Famar Health Care Services
Famar Health Care Services
Request a quote
More information
Recipharm
Recipharm
Request a quote
More information
Sandoz
Sandoz
Request a quote
More information
<< 1 >>
Showing Results 1 - 10 of 10
Scientific News
Adaptimmune Announces Interim Results from Pilot Trial of NY-ESO T Cells
Study reports encouraging response rate and safety profile.
Personalized Ovarian Cancer Vaccines
UConn Researchers have found a new way to identify protein mutations in cancer cells.
Study Finds Potential New Target to Treat Asthma Attacks Brought on by Colds
Results suggest that IL-25 could be a target for possible treatments to prevent asthma attacks.
Novel Drug Targeting Leukemia Cells Enters Clinical Trial
Phase 1 human clinical trial to assess the safety and efficacy of a new monoclonal antibody for CLL patients.
Animal Testing can Mislead Drug Discovery and Development
Several blockbuster drugs would not be on the market, if scientists had relied solely on drug-uptake in animal trials, according to new research.
Leukemia Subtype Becomes More Common With Age
Genomic Analysis of 1,725 patients reveals the prevalence of Ph-like ALL increases with age.
Clinical Trial to Test Safety of Stem Cell-Derived Therapy for Type 1 Diabetes
UC San Diego is initial site for first-in-human testing of implanted cell therapy.
NIH to Launch Human Safety Study of Ebola Vaccine Candidate
Trial is First in Series of Accelerated Safety Studies of Ebola Vaccines.
NIH Announces the Launch of 3 Integrated Precision Medicine Trials
ALCHEMIST is for patients with certain types of early-stage lung cancer.
Monthly Blood Transfusions Reduce Sickle Cell Anemia-related Brain Injury in Children
NIH-funded study provides hope for children with disease-related brain damage.
Scroll Up
Scroll Down
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv